These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 10424723

  • 1. Role of thromboxane A2 and platelet activating factor in early haemodynamic response to lipopolysaccharide in rats.
    Bocheński J, Chłopicki S, Gryglewski RJ.
    J Physiol Pharmacol; 1999 Jun; 50(2):287-97. PubMed ID: 10424723
    [Abstract] [Full Text] [Related]

  • 2. Endotoxaemia in rats: role of NO, PAF and TXA2 in pulmonary neutrophil sequestration and hyperlactataemia.
    Olszanecki R, Chłopicki S.
    J Physiol Pharmacol; 1999 Sep; 50(3):443-54. PubMed ID: 10574473
    [Abstract] [Full Text] [Related]

  • 3. Involvement of platelet activating factor in immediate heart response to lipopolysaccharide.
    Jakubowski A, Olszanecki R, Chlopicki S.
    J Physiol Pharmacol; 2004 Jun; 55(2):409-21. PubMed ID: 15213362
    [Abstract] [Full Text] [Related]

  • 4. Biphasic response to lipopolysaccharide from E. coli in the isolated ventilated blood-perfused rat lung.
    Chlopicki S, Bartuś JB, Gryglewski RJ.
    J Physiol Pharmacol; 1999 Dec; 50(4):551-65. PubMed ID: 10639006
    [Abstract] [Full Text] [Related]

  • 5. Pneumotoxicity of lipopolysaccharide in nitric oxide-deficient rats is limited by a thromboxane synthase inhibitor.
    Wołkow PP, Bartuś JB, Gryglewski RJ.
    J Physiol Pharmacol; 1997 Dec; 48(4):645-53. PubMed ID: 9444613
    [Abstract] [Full Text] [Related]

  • 6. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
    Akagi M, Nishioka E, Kanoh R, Tachibana M, Fukuishi N.
    Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
    [Abstract] [Full Text] [Related]

  • 7. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
    László F, Whittle BJ, Moncada S.
    Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265
    [Abstract] [Full Text] [Related]

  • 8. Roles of thromboxane A2 and 5-hydroxytryptamine in endotoxin-induced digital vasoconstriction in horses.
    Menzies-Gow NJ, Sepulveda MF, Bailey SR, Cunningham FM, Elliott J.
    Am J Vet Res; 2008 Feb; 69(2):199-207. PubMed ID: 18241016
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086.
    Wilson DV, Eberhart SW, Robinson NE, Rice R, Gray PR.
    Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938
    [Abstract] [Full Text] [Related]

  • 10. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
    Clavijo LC, Carter MB, Matheson PJ, Wills-Frank LA, Wilson MA, Wead WB, Garrison RN.
    J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
    [Abstract] [Full Text] [Related]

  • 11. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.
    Rabinovici R, Yue TL, Farhat M, Smith EF, Esser KM, Slivjak M, Feuerstein G.
    J Pharmacol Exp Ther; 1990 Oct; 255(1):256-63. PubMed ID: 2213560
    [Abstract] [Full Text] [Related]

  • 12. Platelet activating factor impairs pressor responses to noradrenaline in the anaesthetized rat but does not mediate endotoxin-induced hyporeactivity.
    Bouvier C, Guc MO, Furman BL, Parratt JR.
    Circ Shock; 1994 Jan; 42(1):14-9. PubMed ID: 8149505
    [Abstract] [Full Text] [Related]

  • 13. Involvement of platelet-activating factor in the hypotensive response to zymosan in rats.
    Damas J.
    J Lipid Mediat; 1991 Jan; 3(3):333-44. PubMed ID: 1773031
    [Abstract] [Full Text] [Related]

  • 14. Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.
    Filep JG, Fournier A, Földes-Filep E.
    Br J Pharmacol; 1994 Jul; 112(3):963-71. PubMed ID: 7921626
    [Abstract] [Full Text] [Related]

  • 15. Role of platelet-activating factor and thromboxane A2 in radical production during ischemia and reperfusion of the rat brain.
    Matsuo Y, Kihara T, Ikeda M, Ninomiya M, Onodera H, Kogure K.
    Brain Res; 1996 Feb 19; 709(2):296-302. PubMed ID: 8833766
    [Abstract] [Full Text] [Related]

  • 16. [Effects of thromboxane on pulmonary arterial response to platelet activating factor in rabbit].
    Enzan K, Komatsu H, Shoji K, Suzuki M.
    Masui; 1995 May 19; 44(5):633-42. PubMed ID: 7609288
    [Abstract] [Full Text] [Related]

  • 17. Platelet activating factor mediates interleukin-2-induced lung injury in the rat.
    Rabinovici R, Sofronski MD, Renz JF, Hillegas LM, Esser KM, Vernick J, Feuerstein G.
    J Clin Invest; 1992 May 19; 89(5):1669-73. PubMed ID: 1314853
    [Abstract] [Full Text] [Related]

  • 18. Roles of platelet-activating factor, thromboxane A2, ADP and thrombin in thrombogenesis in the guinea pig.
    Hirata Y, Takiguchi Y, Wada K, Matsuno H, Umemura K, Uematsu T, Nakashima M.
    Eur J Pharmacol; 1993 Feb 16; 231(3):421-5. PubMed ID: 8449234
    [Abstract] [Full Text] [Related]

  • 19. Platelet-activating factor increases vascular resistance in rat hindquarters by thromboxane A2.
    Rizzo A, Taylor AE, Townsley MI, Logsdon P, Khimenko PL, Fletcher JR.
    Am J Physiol; 1995 May 16; 268(5 Pt 2):H1954-8. PubMed ID: 7771545
    [Abstract] [Full Text] [Related]

  • 20. A triazolodiazepine platelet activating factor receptor antagonist (WEB 2086) reduces pulmonary dysfunction during endotoxin shock in swine.
    Siebeck M, Weipert J, Keser C, Kohl J, Spannagl M, Machleidt W, Schweiberer L.
    J Trauma; 1991 Jul 16; 31(7):942-9; discussion 949-50. PubMed ID: 1906548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.